Westfield Capital Management’s West Pharmaceutical WST Stock Holding History

Westfield Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,700	Closed	-$463K	–	256
2019 Q2	$463K	Hold	3,700	–	–	﹤0.01%	231
2019 Q1	$408K	Hold	3,700	–	–	﹤0.01%	232
2018 Q4	$363K	Hold	3,700	–	–	﹤0.01%	236
2018 Q3	$457K	Hold	3,700	–	–	﹤0.01%	237
2018 Q2	$367K	Buy	+3,700	New	+$341K	﹤0.01%	238
2018 Q1	–	Sell	-3,700	Closed	-$365K	–	267
2017 Q4	$365K	Hold	3,700	–	–	﹤0.01%	237
2017 Q3	$356K	Buy	+3,700	New	+$335K	﹤0.01%	237

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Westfield Capital Management's WST Position: Q3 2019 in Review

Westfield Capital Management sold out of West Pharmaceutical (WST) in Q3 2019, closing a stake of 3,700 shares — an estimated $463K sold.

Westfield Capital Management first reported a position in WST in Q3 2017 and held it in 7 quarters. The position peaked at $463K in Q2 2019. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

Westfield Capital Management reported no remaining West Pharmaceutical position as of Q3 2019 after selling out during the quarter.
Westfield Capital Management sold 3,700 West Pharmaceutical shares in Q3 2019, an estimated $463K.
Westfield Capital Management first reported a position in West Pharmaceutical in Q3 2017 and held it in 7 quarters.
Westfield Capital Management's West Pharmaceutical position peaked at $463K in Q2 2019.
406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Westfield Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.